Anorectal Mucosal Melanoma: A Case Report and Literature Review

被引:11
作者
Junior, Jose Donizeti de Meira [1 ]
Sobrado, Lucas Faraco [1 ]
Guzela, Vivian M. [1 ]
Nahas, Sergio Carlos [1 ]
Sobrado, Carlos Walter [1 ]
机构
[1] Univ Sao Paulo, Colorectal Surg Div, Dept Gastroenterol, Clin Hosp,Sch Med, Sao Paulo, SP, Brazil
基金
英国科研创新办公室;
关键词
Colorectal Surgery; Margins of Excision; Melanoma; Rectal Diseases; Treatment Outcome; SURGICAL-MANAGEMENT; MALIGNANT-MELANOMA; THERAPY;
D O I
10.12659/AJCR.933032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Rare disease Background: Anorectal mucosal melanoma (AMM) is a rare and aggressive neoplasm, with a 5-year survival rate of 10%. Due to its rarity and nonspecific symptoms, the diagnosis is often made late. Surgical resection remains the criterion standard for treatment of anorectal melanoma. Case Report: We present the case of an 81-year-old woman presenting with hematochezia, anal secretion, tenesmus, difficulty in defecation, and perianal pain. On physical examination, there was a prolapse of a 5-cm melanocytic nodule in the anal canal, hard on palpation. Biopsy confirmed anorectal melanoma. Staging revealed anal and metastatic disease, with adrenal, lymphatic, and hepatic involvement. As the patient continued to have bleeding, severe pain, and difficulty in defecation, she was submitted to a wide local excision. At 5-month followup, the anal lesion had relapsed, and the patient died 10 months after the procedure. Conclusions: AMM is a rare and extremely aggressive tumor. Symptoms are nonspecific but early diagnosis should be pursued to allow curative treatment. Surgical resection with free margins is the goal of surgical treatment. New therapies are being studied, including immunotherapy, which can improve the dismal prognosis of this rare disease.
引用
收藏
页数:5
相关论文
共 24 条
[1]   KIT Gene Mutations and Copy Number in Melanoma Subtypes [J].
Beadling, Carol ;
Jacobson-Dunlop, Erick ;
Hodi, F. Stephen ;
Le, Claudia ;
Warrick, Andrea ;
Patterson, Janice ;
Town, Ajia ;
Harlow, Amy ;
Cruz, Frank, III ;
Azar, Sharl ;
Rubin, Brian P. ;
Muller, Susan ;
West, Rob ;
Heinrich, Michael C. ;
Corless, Christopher L. .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6821-6828
[2]   Anal Versus Rectal Melanoma: Does Site of Origin Predict Outcome? [J].
Bello, Danielle M. ;
Smyth, Elizabeth ;
Perez, Daniel ;
Khan, Shaheer ;
Temple, Larissa K. ;
Ariyan, Charlotte E. ;
Weiser, Martin R. ;
Carvajal, Richard D. .
DISEASES OF THE COLON & RECTUM, 2013, 56 (02) :150-157
[3]   Surgical therapy for anorectal melanoma [J].
Bullard, KM ;
Tuttle, TM ;
Rothenberger, DA ;
Madoff, RD ;
Baxter, NN ;
Finne, CO ;
Spencer, MP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 196 (02) :206-211
[4]  
Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO
[5]  
2-G
[6]   Sentinel node mapping in anorectal melanoma [J].
Duport, C. ;
Tiffet, O. ;
Perrot, J. -L. ;
Prevot, N. ;
Rey, Y. ;
Cambazard, F. .
ANNALES DE CHIRURGIE, 2006, 131 (09) :550-552
[7]   Endoscopic appearance of primary anorectal melanoma [J].
Gupta, R ;
Rathi, PM ;
Sawant, P ;
Shroff, CP ;
Upadhyay, AP ;
Bhatnagar, MS .
ENDOSCOPY, 1997, 29 (03) :230-230
[8]   Major response to imatinib mesylate in KIT-mutated melanoma [J].
Hodi, F. Stephen ;
Friedlander, Philip ;
Corless, Christopher L. ;
Heinrich, Michael C. ;
Mac Rae, Suzanne ;
Kruse, Andrea ;
Jagannathan, Jyothi ;
Van den Abbeele, Annick D. ;
Velazquez, Elsa F. ;
Demetri, George D. ;
Fisher, David E. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2046-2051
[9]  
Hodi FS, 2015, J CLIN ONCOL, V33
[10]   Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].
Kirkwood, JM ;
Strawderman, MH ;
Ernstoff, MS ;
Smith, TJ ;
Borden, EC ;
Blum, RH .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17